Navigation Links
Space scientists, humanist scholars to explore outer space from new perspective
Date:9/13/2007

The seminar was attended by 21 leading thinkers from diverse humanist and scientific disciplines, 10 of whom presented short papers.

Gsli P lsson, for example, an anthropologist from the University of Iceland in Reykjavik, presented Lucy in the Sky Out of Africa, Out of Earth, in which he looked at whether our understanding of how human cultures interact can help us imagine what it would be like to contact non-human cultures.

The seminar was also attended by a luminary in historical research, Dr Alfred Crosby, who originated the concept of the Columbian Exchange in the 1970s. He presented a paper entitled The Space-Roving Human Being and His and Her Inhabitants: Micro-Organisms and Extraterrestrial Travel.

The science community does not really seem to be aware of the fact that a number of issues and concerns that they are dealing with, such as the consequences of meeting with unknown pathogens, are known and have long been studied by historians and ethnologists, Prof Codignola offered.

As for the humanities scholars, technical difficulties relating to space voyaging and especially its time frame, usually escape them. We all felt it was rather strange that the two groups rarely, if ever, meet to discuss space-related issues, he added.

The upcoming Vienna conference will feature six successive sessions and 21 speakers. The conclusions from these sessions will be documented by the ESF in a position paper entitled Vienna Vision on Humans in Outer Space. The ESF will distribute this paper to all interested stakeholders in the academic world, space agencies, intergovernmental bodies such as the United Nations, the media and politicians involved in space and research-related initiatives.

Prof Kai-Uwe Schrogl, Secretary General of the ESPI and Chair of the conference, commented: Mankinds future in outer space will require a comprehensive view including the input in particular by the humanities and social sciences, as w
'/>"/>

Contact: Dr. Jean-Claude Worms
jcworms@esf.org
33-038-876-7188
European Science Foundation
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Immune cells halt round in space
2. Space research leads to needle-free blood tests
3. Doctors Ask MPs To Protect Human Rights By Banning Smoking In Enclosed Public Spaces
4. Space suit technology to Protect Against Heat Strokes
5. Needed, more space for womens sexual identity on marquees
6. Spacers Score Over Nebulizers in Childhood Asthma Treatment
7. Astronauts Spacewalk On The International Space Station – NASA Report
8. Effect of Prolonged Stay in Space Studied Using Fruit Flies
9. Exercise in Space Prevents Kidney Stone Formation in Astronauts
10. Headspace to the Rescue of Mentally Ill Youngsters
11. Experiments In Outer Space To Determine single Cell Survival
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 1AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 1Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 3PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 1PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 2
Other Medicine Technology:Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10